EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 22 filers reported holding EVOKE PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $26,000 | -50.0% | 45,892 | +15.4% | 0.00% | – |
| Q3 2021 | $52,000 | -63.6% | 39,769 | -61.6% | 0.00% | – |
| Q2 2021 | $143,000 | +30.0% | 103,529 | +72.0% | 0.00% | – |
| Q1 2021 | $110,000 | -47.6% | 60,200 | -26.1% | 0.00% | – |
| Q4 2020 | $210,000 | -71.0% | 81,500 | -47.2% | 0.00% | – |
| Q3 2020 | $725,000 | +2238.7% | 154,427 | +480.5% | 0.00% | – |
| Q1 2020 | $31,000 | -16.2% | 26,602 | -54.9% | 0.00% | – |
| Q2 2019 | $37,000 | +42.3% | 59,047 | +404.4% | 0.00% | – |
| Q4 2017 | $26,000 | -23.5% | 11,706 | -30.1% | 0.00% | – |
| Q4 2016 | $34,000 | – | 16,751 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 87,925 | $48,000 | 0.01% |
| Wambolt & Associates, LLC | 32,000 | $18,000 | 0.01% |
| Virtu Financial LLC | 55,336 | $31,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 183 | $0 | 0.00% |
| NORTHERN TRUST CORP | 42,121 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 3,828 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 210,102 | $117,000 | 0.00% |
| STATE STREET CORP | 72,800 | $41,000 | 0.00% |
| MORGAN STANLEY | 9,606 | $5,000 | 0.00% |